Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
7,322
-17
-0.2% -$786 0.02% 263
2026
Q1
$360K Sell
7,339
-56
-0.8% -$2.6K 0.03% 255
2025
Q4
$322K Buy
7,395
+96
+1% +$4.38K 0.03% 261
2025
Q3
$329K Buy
7,299
+1
+0% +$44 0.03% 255
2025
Q2
$317K Buy
7,298
+55
+0.8% +$2.45K 0.03% 260
2025
Q1
$334K Buy
7,243
+18
+0.2% +$752 0.03% 253
2024
Q4
$272K Hold
7,225
0.03% 262
2024
Q3
$293K Hold
7,225
0.03% 245
2024
Q2
$250K Hold
7,225
0.03% 238
2024
Q1
$271K Buy
+7,225
New +$258K 0.03% 225

Other funds holding EXC

CGN Advisors's EXC Position: Q2 2026 in Review

CGN Advisors reduced its Exelon (EXC) stake by 0.23% in Q2 2026, selling an estimated $786 and leaving 7,322 shares worth $341K. The position accounts for 0.02% of the portfolio, ranked #263.

CGN Advisors first reported a position in EXC in Q1 2024 and has held it in 10 quarters since. The position peaked at $360K in Q1 2026. 175 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • CGN Advisors held 7,322 shares of Exelon worth $341K as of Q2 2026.
  • CGN Advisors sold 17 Exelon shares in Q2 2026, an estimated $786.
  • Exelon made up 0.02% of CGN Advisors's portfolio in Q2 2026, its #263 holding.
  • CGN Advisors first reported a position in Exelon in Q1 2024 and has held it in 10 quarters since.
  • CGN Advisors's Exelon position peaked at $360K in Q1 2026.
  • 175 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.